London, UK, 22 December 2006: BTG plc (LSE: BGC), the medical innovations company, today announces that it has granted Fresenius Medical Care AG & Co. KGaA a non-exclusive licence for the global rights to patents relating to a haemofiltration device for €4.5 million fully paid.
